Radius Health (RDUS) sees Significant Insider buy Extending Trend of purchases over Last Quarter

Friday, August 11, 2017 10:15 PM ET

Radius Health (RDUS) sees Significant Insider buy Extending Trend of purchases over Last Quarter

One Radius Health insider — Biotech Growth N V, 10% Owner — today, purchased 150,000 shares having a market value of approximately $5,245,028, as disclosed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 180,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 330,000 shares and have averaged 165,000 shares per transaction over this time period.

The number of insider buy/sell trades at Radius Health is greater than the 263 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 312 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Radius Health insiders was also higher. Within the peer group there were 7,064,554 shares purchased and 15,844,950 shares sold with company insiders having sold 28,142 shares on average.

The data sourced in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.